<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Canadian Pharmacy Blog &#187; Singulair</title>
	<atom:link href="http://annpharmacy.com/blog/tag/singulair/feed" rel="self" type="application/rss+xml" />
	<link>http://annpharmacy.com/blog</link>
	<description>Health, Diseases, Drugs &#38; medications, Online canadian pharmacy</description>
	<lastBuildDate>Wed, 25 May 2011 13:02:23 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.2</generator>
		<item>
		<title>SINGULAIR (Montelukast Sodium) Prevents Exercise-Induced Bronchoconstriction</title>
		<link>http://annpharmacy.com/blog/asthma/singulair-montelukast-sodium-prevents-exercise-induced-bronchoconstriction.html</link>
		<comments>http://annpharmacy.com/blog/asthma/singulair-montelukast-sodium-prevents-exercise-induced-bronchoconstriction.html#comments</comments>
		<pubDate>Sat, 02 Jan 2010 12:58:26 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[Anti-Allergic]]></category>
		<category><![CDATA[Asthma]]></category>
		<category><![CDATA[allergic rhinitis]]></category>
		<category><![CDATA[Montelukast]]></category>
		<category><![CDATA[Singulair]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=138</guid>
		<description><![CDATA[It has been known today that generic Singulair is effective in preventing exercise-induced bronchoconstriction (EIB). According to the update facts by Merck &#38; Co., Inc. a new indication is useful in patients aged 15 years and older. The efficacy of SINGULAIR 10 mg was investigated in three randomized, double-blind, placebocontrolled crossover studies in 160 patients [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/asthma/singulair-montelukast-sodium-prevents-exercise-induced-bronchoconstriction.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pittsburgh Study About Effectiveness Of Asthma Medication In The Common Cold</title>
		<link>http://annpharmacy.com/blog/asthma/pittsburgh-study-about-effectiveness-of-asthma-medication-in-the-common-cold.html</link>
		<comments>http://annpharmacy.com/blog/asthma/pittsburgh-study-about-effectiveness-of-asthma-medication-in-the-common-cold.html#comments</comments>
		<pubDate>Fri, 25 Dec 2009 09:49:16 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[Anti-Allergic]]></category>
		<category><![CDATA[Asthma]]></category>
		<category><![CDATA[allergic rhinitis]]></category>
		<category><![CDATA[allergy medicine]]></category>
		<category><![CDATA[Montelukast]]></category>
		<category><![CDATA[Singulair]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=133</guid>
		<description><![CDATA[At the annual meeting of the American Academy of Allergy, Asthma and Immunology in San Diego new investigation is presented. The aim of the study conducted by physicians in the Division of Allergy, Asthma and Immunology at Allegheny General Hospital (AGH) in Pittsburgh was to reveal if Singulair (Montelukast) drug may provide relief for the [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/asthma/pittsburgh-study-about-effectiveness-of-asthma-medication-in-the-common-cold.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Reports About Singulair Medication</title>
		<link>http://annpharmacy.com/blog/asthma/fda-reports-about-singulair-medication.html</link>
		<comments>http://annpharmacy.com/blog/asthma/fda-reports-about-singulair-medication.html#comments</comments>
		<pubDate>Tue, 15 Dec 2009 12:41:33 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[Anti-Allergic]]></category>
		<category><![CDATA[Asthma]]></category>
		<category><![CDATA[allergic rhinitis]]></category>
		<category><![CDATA[Montelukast]]></category>
		<category><![CDATA[Singulair]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=129</guid>
		<description><![CDATA[The US Food and Drug Administration (FDA) investigates a prescription drug Singulair (Montelukast) used in treating asthma and allergic rhinitis. It intends to reveal a potential link between the drug&#8217;s use and changes to behavior and mood, suicide, and suicidal thinking and behavior if it takes place. According to the announcement made on 27th of [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/asthma/fda-reports-about-singulair-medication.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Singulair(R) Is also Indicated For Perennial Allergic Rhinitis</title>
		<link>http://annpharmacy.com/blog/asthma/singulairr-is-also-indicated-for-perennial-allergic-rhinitis.html</link>
		<comments>http://annpharmacy.com/blog/asthma/singulairr-is-also-indicated-for-perennial-allergic-rhinitis.html#comments</comments>
		<pubDate>Fri, 04 Dec 2009 10:32:03 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[Anti-Allergic]]></category>
		<category><![CDATA[Asthma]]></category>
		<category><![CDATA[allergic rhinitis]]></category>
		<category><![CDATA[Montelukast]]></category>
		<category><![CDATA[SAR]]></category>
		<category><![CDATA[Singulair]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=125</guid>
		<description><![CDATA[It has been proven that taking Singulair tablets once a day help relieve a variety of indoor and outdoor allergy symptoms for up to 24 hours. Gailen Marshall Jr., M.D., Ph.D., director of the Division of Clinical Immunology and Allergy at the University of Mississippi Medical Center in Jackson, MS, considers allergic rhinitis to be [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/asthma/singulairr-is-also-indicated-for-perennial-allergic-rhinitis.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Study Of Generic Singulair</title>
		<link>http://annpharmacy.com/blog/asthma/new-study-of-generic-singulair.html</link>
		<comments>http://annpharmacy.com/blog/asthma/new-study-of-generic-singulair.html#comments</comments>
		<pubDate>Wed, 25 Nov 2009 09:22:43 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[Asthma]]></category>
		<category><![CDATA[Montelukast]]></category>
		<category><![CDATA[Singulair]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=121</guid>
		<description><![CDATA[New data based on Food and Drug Administration investigation into Singulair (Montelukast) don’t confirm a link between this kind of asthma medicine and suicide. This statement is released by Leadership from the American Academy of Allergy Asthma &#38; Immunology and the American College of Allergy, Asthma &#38; Immunology. Besides FDA is confident in lacking of [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/asthma/new-study-of-generic-singulair.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Updated Information About SINGULAIR DRUG and other Leukotriene Inhibitors</title>
		<link>http://annpharmacy.com/blog/asthma/the-updated-information-about-singulair-drug-and-other-leukotriene-inhibitors.html</link>
		<comments>http://annpharmacy.com/blog/asthma/the-updated-information-about-singulair-drug-and-other-leukotriene-inhibitors.html#comments</comments>
		<pubDate>Mon, 16 Nov 2009 13:56:27 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[Asthma]]></category>
		<category><![CDATA[allergic rhinitis]]></category>
		<category><![CDATA[Montelukast]]></category>
		<category><![CDATA[PAR]]></category>
		<category><![CDATA[SAR]]></category>
		<category><![CDATA[Singulair]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=117</guid>
		<description><![CDATA[Singulair (Montelukast) was introduced in 1998. Generic Singulair is indicated for the patients on asthma aged from children of 12 months and older. This Asthma medicine is used for the relief of symptoms of seasonal allergic rhinitis (SAR) in adults and children 2 years and older, and for the relief of symptoms of perennial allergic [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/asthma/the-updated-information-about-singulair-drug-and-other-leukotriene-inhibitors.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

